|
|||||
|
|
Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT |
|
| Authors: | Christina Rautenberg Kathrin Nachtkamp Ariane Dienst Pia Verena Schmidt Claudia Heyn Mustafa Kondakci Ulrich Germing Rainer Haas Guido Kobbe Thomas Schroeder |
| Affiliation: | Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany |
| Abstract: | |
| Keywords: | acute myeloid leukemia FLT3 relapse allogeneic transplantation sorafenib azacitidine |
